Theravance Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MADISON AVENUE PARTNERS, LP | 02/14/2025 | 9.51 M | $89.50 M | 0.00% | 19.40% |
| WEISS ASSET MANAGEMENT LP | 02/14/2025 | 7.46 M | $70.17 M | 0.00% | 15.21% |
| NEWTYN MANAGEMENT, LLC | 02/14/2025 | 4.76 M | $44.77 M | 5.74% | 9.70% |
| BLACKROCK, INC. | 02/07/2025 | 3.71 M | $34.93 M | -0.51% | 7.57% |
| IRENIC CAPITAL MANAGEMENT LP | 02/14/2025 | 2.76 M | $25.98 M | 0.00% | 5.63% |
| VANGUARD GROUP INC | 02/11/2025 | 2.01 M | $18.92 M | -2.01% | 4.10% |
| PARK WEST ASSET MANAGEMENT LLC | 02/14/2025 | 1.79 M | $16.87 M | -3.76% | 3.66% |
| STATE STREET CORP | 02/14/2025 | 1.22 M | $11.50 M | 2.59% | 2.49% |
| OASIS MANAGEMENT CO LTD. | 02/14/2025 | 1.12 M | $10.50 M | 0.00% | 2.28% |
| CAMBER CAPITAL MANAGEMENT LP | 02/14/2025 | 1.00 M | $9.41 M | 0.00% | 2.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 862,802 | $8.12 M | 0.56% | 1.76% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 833,943 | $7.85 M | 9.05% | 1.70% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 553,713 | $5.21 M | 20.79% | 1.13% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 495,727 | $4.66 M | 10.88% | 1.01% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 481,475 | $4.53 M | 2.69% | 0.98% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 438,463 | $4.13 M | -23.94% | 0.89% |
| MORGAN STANLEY | 02/14/2025 | 392,333 | $3.69 M | -20.87% | 0.80% |
| NORTHERN TRUST CORP | 02/14/2025 | 389,980 | $3.67 M | 1.62% | 0.80% |
| CITADEL ADVISORS LLC | 02/14/2025 | 314,622 | $2.96 M | 34.14% | 0.64% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 305,615 | $2.88 M | 0.04% | 0.62% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 293,936 | $2.77 M | 0.71% | 0.60% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 262,896 | $2.47 M | 0.00% | 0.54% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 225,103 | $2.12 M | -22.32% | 0.46% |
| JPMORGAN CHASE & CO | 02/12/2025 | 219,568 | $2.07 M | -17.73% | 0.45% |
| MACQUARIE GROUP LTD | 02/14/2025 | 208,783 | $1.97 M | 0.00% | 0.43% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 198,491 | $1.87 M | 3.74% | 0.40% |
| TUDOR INVESTMENT CORP ET AL | 02/14/2025 | 196,578 | $1.85 M | 0.00% | 0.40% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 192,839 | $1.81 M | 71.11% | 0.39% |
| UBS GROUP AG | 02/14/2025 | 174,245 | $1.64 M | 466.52% | 0.36% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 162,987 | $1.53 M | -29.07% | 0.33% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 151,083 | $1.42 M | 50.70% | 0.31% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 150,039 | $1.41 M | 27.69% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 115,779 | $1.09 M | -4.36% | 0.24% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 100,807 | $948,594 | -9.70% | 0.21% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 77,931 | $733,331 | 11.90% | 0.16% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 77,155 | $726,029 | -2.16% | 0.16% |
| BARCLAYS PLC | 02/13/2025 | 74,790 | $704,000 | 14.04% | 0.15% |
| SWISS NATIONAL BANK | 02/10/2025 | 71,742 | $675,092 | 0.00% | 0.15% |
| MARSHALL WACE, LLP | 02/13/2025 | 66,067 | $621,690 | -55.97% | 0.13% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 64,795 | $610,000 | 16.79% | 0.13% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 60,907 | $573,135 | 0.00% | 0.12% |
| RHUMBLINE ADVISERS | 01/30/2025 | 59,961 | $564,219 | -4.93% | 0.12% |
| MARTINGALE ASSET MANAGEMENT L P | 02/13/2025 | 58,650 | $551,897 | 7.71% | 0.12% |
| NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | 02/06/2025 | 58,142 | $547,116 | 0.00% | 0.12% |
| STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 58,001 | $545,789 | -49.25% | 0.12% |
| JANE STREET GROUP, LLC | 02/14/2025 | 52,344 | $492,557 | -63.79% | 0.11% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 47,168 | $443,851 | -52.33% | 0.10% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 46,550 | $438,036 | 50.44% | 0.09% |
| INVESCO LTD. | 02/13/2025 | 46,050 | $433,331 | 3.54% | 0.09% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 41,218 | $387,861 | -23.78% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Theravance Biopharma, Inc. institutional Ownership - FAQ's
During the previous two years, 178 institutional investors and hedge funds held shares of Theravance Biopharma, Inc.. The most heavily invested institutionals were:
Madison Avenue Partners, LP: 9.51 M
Weiss Asset Management LP: 7.46 M
Newtyn Management, LLC: 4.76 M
BlackRock, Inc.: 3.71 M
Irenic Capital Management LP: 2.76 M
VANGUARD GROUP INC: 2.01 M
91.54% of Theravance Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 71.82 M shares in the last 24 months. This purchase volume represents approximately $603.32 M in transactions.